MD Magazine (10/8, Bahrenburg) reports, “In the treatment of schizophrenia, second generation antipsychotic medications are significantly less likely to cause tardive dyskinesia…than first generation antipsychotics,” researchers concluded in a meta-analysis, the findings of which were published online Sept. 7 in the journal World Psychiatry.
Related Links:
— “Reduced Risk of Tardive Dyskinesia with 2nd-Generation Antipsychotics Re-Established, “Caitlyn Bahrenburg, MD Magazine, October 8, 2018.